To stay ahead of competitors in a data-driven world, you need to continuously overhaul your processes and technologies. A data and AI transformation program is needed, but often there are so many stakeholders and so many possible paths that many organizations don't know where to begin.
In this session three pharmaceutical executives, with experience as Chief Data Officers and strategic consultants, discuss techniques to improve your digital capabilities. You'll get practicable advice on implementing a data and AI transformation program, from determining the people who need to be involved, to improving processes and successfully adopting new tools.
Tracy RingCDO and Global Generative AI lead for Life Sciences at Accenture
Tracy Ring leads Accenture’s Applied Intelligence Products Category Group, in this role she has leadership across Consumer and Industrial Products, Automotive, Life Sciences, Retail and Aerospace and Defense. As the CDO and Global Generative AI lead for Life Sciences, she personally anchors the NA Applied Intelligence Life Sciences practice of more than 500 practitioners. Tracy has created solutions for Generative AI, Data led transformation, Artificial Intelligence, Data and Cloud Modernization, Analytics, and the organization and operating model strategies for next-generation adoption and AI fluency.
Christian Born DjurhuusOwner at Djurhuus Consulting
Christian is a pharma executive providing consultancy services on drug development, precision medicine and adding value through digital transformation. He was previously Chief Digital Officer for Development at Novo Nordisk.
Gabriel EichlerManaging Director at Oak Health Partners
Garbriel runs Oak Health Partners, a boutique healthcare consultancy. He provides strategic services specializing in healthtech, biopharma, and precision medicine. He was previously Chief Data Officer for the Data42 transformational R&D program at Novartis.